课题基金 / 基金详情

TREATMENT OF FEMALES WITH COCAINE ABUSE

TREATMENT OF FEMALES WITH COCAINE ABUSE
女性可卡因滥用的治疗
批准号:
6104116
负责人:
SHEILA Mary SPECKER
金额:
$15.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2001-02-28

项目摘要

项目成果

SHEILA Mary SPECKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this two part proposal is to determine the effectiveness of a new pharmacologic agent, ritanserin, in the treatment of women with cocaine abuse. Compared to men, women exhibit a more rapid course of cocaine addiction and do worse in treatment. In addition, they are underrepresented in drug abuse studies. Ritanserin, a selective 5-HT2 serotonin antagonist, has been shown to decrease cocaine use in rats, decrease alcohol intake and depression in humans, and has a good safety profile. Additionally, it appears to have no abuse potential. Study 1 will evaluate the effects of ritanserin on cocaine self- administration in both depressed and non-depressed women with cocaine abuse. This study is a four week, double-blind trial of 84 depressed and 84 non-depressed subjects randomized into ritanserin or placebo conditions. Outcome will be determined by urine drug screens, drug use diaries and changes in craving and depression measures. Study 2 will determine the effect of ritanserin on relapse to cocaine use in a six month, double-blind, placebo-controlled trial of 100 depressed and 100 non-depressed women with cocaine abuse. A standardized psychosocial treatment component emphasizing relapse prevention is included in Study 2. Outcome measures include drug screen urinalysis, drug use diaries and changes on craving, depression and relapse scales. Hypotheses to be tested are: (1) ritanserin will decrease both the self- administration of cocaine and relapse to cocaine in both depressed and non-depressed women with a greater effect in depressed women; (2) ritanserin will decrease craving for cocaine; (3) ritanserin will decrease the frequency of relapses to cocaine and the consequences of relapse; and (4) depressive signs and symptoms will be decreased in ritanserin groups as compared to placebo. This work will test the efficacy of a new pharmacologic agent, ritanserin, in the treatment of cocaine abuse. It will also expand upon the limited knowledge of women with cocaine abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
YOUNG ADULTS WITH ADDICTION: IMPULSIVITY, BRAIN DYSFUNCTION AND RECOVERY
  • 批准号:
    8362833
  • 项目类别:
  • 资助金额:
    $0.38万
  • 财政年份:
    2011
  • 负责人:
    SHEILA Mary SPECKER
  • 依托单位:
YOUNG ADULTS WITH ADDICTION: IMPULSIVITY, BRAIN DYSFUNCTION AND RECOVERY
  • 批准号:
    8170438
  • 项目类别:
  • 资助金额:
    $0.32万
  • 财政年份:
    2010
  • 负责人:
    SHEILA Mary SPECKER
  • 依托单位:
YOUNG ADULTS WITH ADDICTION: IMPULSIVITY, BRAIN DYSFUNCTION AND RECOVERY
  • 批准号:
    7954971
  • 项目类别:
  • 资助金额:
    $0.64万
  • 财政年份:
    2009
  • 负责人:
    SHEILA Mary SPECKER
  • 依托单位:
CLINICAL TRIAL: INTERACTIONS BETWEEN PROGESTERONE AND COCAINE
  • 批准号:
    7951657
  • 项目类别:
  • 资助金额:
    $3.48万
  • 财政年份:
    2008
  • 负责人:
    SHEILA Mary SPECKER
  • 依托单位:
海外基金